Go Symbol Lookup
Loading...

Acquisitions

More

  • Nev. regulators approve Pinnacle, Ameristar deal Friday, 17 May 2013 | 10:35 AM ET

    LAS VEGAS-- Nevada regulators have approved Pinnacle Entertainment Inc.' s buyout of rival Ameristar Casinos Inc.. Pinnacle Entertainment Inc. has said the acquisition would save it at least $40 million a year and boost earnings. Ameristar's holdings include casinos in Missouri, Iowa, Colorado, Mississippi, Indiana and Nevada.

  • May 17- Caterpillar Inc has reached a deal to cut $135 million from the price owed for a Chinese mining equipment maker, after accounting irregularities were discovered at the acquired company that forced Caterpillar to take a $580 million impairment charge.

  • SAN FRANCISCO, May 16- Dell Inc, the subject of a takeover battle between activist investor Carl Icahn and the company's billionaire founder, reported a 79 percent slide in profit as personal computer sales continued to shrink.

  • MADRID, May 16- The former head of Spanish bank Caja Madrid, now part of nationalized lender Bankia, was remanded in custody on Thursday over accusations of irregularities in the acquisition of a U.S. bank in 2008, a court statement said.

  • DDR buys shopping malls from Blackstone for $1.46B Wednesday, 15 May 2013 | 5:21 PM ET

    BEACHWOOD, Ohio-- DDR Corp. is buying 30 of 44 U.S. shopping centers from a joint venture it has with private equity firm Blackstone Group LP in a deal worth $1.46 billion, saying it expects to make money by raising rents at the malls and redeveloping them. They include centers in Boston, Chicago, Washington and Minneapolis among others.

  • EXCLUSIVE-Roche exploring sale of diabetes device unit Wednesday, 15 May 2013 | 3:37 PM ET

    NEW YORK, May 15- Swiss drugmaker Roche Holding AG is exploring a sale of its blood glucose meters business, three people familiar with the matter told Reuters on Wednesday, as the industry grapples with increased competition and reimbursement pressure.

  • DeVry acquires Brazilian school Facid Tuesday, 14 May 2013 | 5:33 PM ET

    DOWNERS GROVE, Ill.-- DeVry Inc. said Tuesday that it is acquiring a Brazilian education company, expanding its presence in the country as enrollments drop in the U.S. DeVry is buying privately-held Faculdade Diferencial Integral, known as Facid, for an undisclosed amount.

  • NEW YORK, May 14- A takeover of Mosaic Co is unlikely in the near term and would be affordable to only a handful of players, executives said in an interview on Tuesday.

  • NEW YORK, May 14- Mid-sized U.S. commodities brokerage INTL FCStone Inc said on Tuesday it plans to buy online commodities exchange Cleartrade Exchange in its first major push into Asia and a sign it wants to harness potential growth from regulatory reform. For INTL FCStone, the deal is its first big expansion into the burgeoning Asian market.

  • INTL FCStone strikes deal with Cleartrade Tuesday, 14 May 2013 | 11:40 AM ET

    NEW YORK-- Commodity risk management firm and securities broker INTL FCStone Inc. said Tuesday that it has reached a deal to acquire majority ownership of Cleartrade Exchange over a five-year period. INTL FCStone said the deal will help expand the global reach of both companies. Shares of INTL FCStone added 25 cents to $16.53 in midday trading Tuesday.

  • Iron Mountain buys 3 records management businesses Tuesday, 14 May 2013 | 10:41 AM ET

    BOSTON-- Information storage and management company Iron Mountain has purchased three records management businesses owned by Information Storage Consolidation Co., adding mid-sized companies to its customer base.

  • Hi-Crush buying D&I Silica in $125M deal Tuesday, 14 May 2013 | 7:29 AM ET

    HOUSTON-- Hi-Crush Partners will spend about $125 million to acquire D&I Silica in a cash-and-stock deal that will broaden its operations in Midwest. "We are now well-positioned to deliver our high-quality sand where, when and how our customers want it, and at the best price," Hi-Crush co-CEO Bob Rasmus said.

  • Mayer's Strategy For Making Yahoo 'Cool' Again  Tuesday, 14 May 2013 | 6:51 AM ET

    The tech giant hopes its redesigned look will impress users and investors, reports CNBC's Jon Fortt.

  • DSM CEO: It Takes 'Guts' to Reinvent Yourself  Tuesday, 14 May 2013 | 2:00 AM ET

    Feike Sijbesma, CEO of DSM, talks about the need for companies to "reinvent" themselves and DSM's acquisition strategy.

  • NEW YORK, May 13- The $23 billion sale of ketchup maker H.J.Heinz Co to Berkshire Hathaway Inc and buyout firm 3 G Capital, Avis Budget Group's takeover of Zipcar, and the $6.9 billion leveraged buyout of BMC Software, have one common link: Kirkland& Ellis LLP.

  • Perion Network 1Q results surge on acquisition Monday, 13 May 2013 | 11:56 AM ET

    NEW YORK-- Perion Network Ltd., which offers instant messaging, photo sharing and other online services, said Monday that its net income grew more than sevenfold in the first quarter, bolstered by an acquisition. The Israeli company earned $2.9 million, or 22 cents per share, for the period ended March 31. A year earlier Perion earned $370,000, or 4 cents per share.

  • First Merchants to buy CFS Bancorp for $114.7M Monday, 13 May 2013 | 10:50 AM ET

    MUNCIE, Ind.-- First Merchants Corp. will buy CFS Bancorp Inc. for $114.7 million in an all-stock. Shareholders in CFS, based in Munster, Ind., will receive 0.65 shares of First Merchants common stock for each of their CFS shares.

  • DUBLIN, May 13- Irish drugmaker Elan Corporation has agreed a $1 billion royalties deal that could soothe concerns about its potentially risky acquisition strategy and fend off a takeover bid from Royalty Pharma.

  • Elan Strikes $1 Billion Royalty Deal With Theravance Monday, 13 May 2013 | 6:45 AM ET

    Elan stepped up its bid to keep its independence on Monday by agreeing a $1 billion deal to buy 21 percent of the royalties that U.S. company Theravance receives from GlaxoSmithKline.

  • *Elan to acquire newly approved Breo as part of $1 bln deal. DUBLIN, May 13- Elan stepped up its bid to keep its independence on Monday by agreeing a $1 billion deal to buy 21 percent of the royalties that U.S. company Theravance receives from GlaxoSmithKline for its respiratory drugs.